# Documents Updated - January 2026

## Summary of Changes

Based on Jeff's feedback, both developer documents have been updated with critical context:

---

## Key Updates Made

### 1. **Kearl ROI Clarification**
✅ **Added context:** $260k is a baseline, reverse-engineered opportunity analysis
✅ **Clarified:** Kearl pilot used traditional HRMS, not our system
✅ **Positioned:** Shows "what would have been possible" with high-frequency monitoring
✅ **Emphasized:** This is a floor, not a ceiling - actual value likely higher

### 2. **Biosensor Details Flexibility**
✅ **Softened specifics:** Removed prescriptive Panel 2 format details
✅ **Added note:** Output formats and reporting structures still being determined
✅ **Design guidance:** Build for flexibility in data ingestion and display

### 3. **Data Integrity as Core Requirement**
✅ **Elevated priority:** Moved from nice-to-have to CRITICAL requirement
✅ **Added details:**
   - Immutable storage (regulatory requirement)
   - Auditable chain of custody
   - Text-based in graph database (AI-readable)
   - Traceable with timestamps and lineage
✅ **Positioned:** Not optional - core for regulatory compliance and social license

### 4. **Crawl, Walk, Run Methodology**
✅ **Added MVP framework:** Build one complete outcome first (recommend: Anomaly Detection)
✅ **Defined MVP success:** Operator receives alert → sees cause → takes action → data auditable
✅ **Phased approach:**
   - Phase 1 (Crawl): MVP with immutable storage
   - Phase 2 (Walk): Intelligence + correlation
   - Phase 3 (Run): Context + transparency
   - Phase 4 (Sprint): Predictive (only after validation)
✅ **Key principle:** Don't build Phase 4 until Phases 1-3 validated with real users

### 5. **Prioritization Framework**
✅ **Added P0/P1/P2 labels:**
   - P0 (Must-Have): MVP cannot launch without
   - P1 (Should-Have): Significantly improves experience
   - P2 (Nice-to-Have): Future enhancement after validation

---

## Documents Ready to Send

### Document 1: Executive Brief
**Location:** `/sessions/gifted-vibrant-euler/mnt/Internal-Papers/Squarehead-Foundry-Executive-Brief.md`

**What changed:**
- Added Kearl methodology clarification (opportunity analysis, not delivered system)
- Added biosensor flexibility note
- Elevated data integrity to CRITICAL requirement
- Added MVP framework and crawl/walk/run phases
- Softened ROI ceiling language

**Best for:** Initial developer orientation, quick reference

---

### Document 2: Detailed Deep Dive
**Location:** `/sessions/gifted-vibrant-euler/mnt/Internal-Papers/Squarehead-Foundry-Customer-Outcomes.md`

**What changed:**
- Added prominent "How These Numbers Were Derived" section after Kearl results
- Softened biosensor technical specifics (Panel 2 format TBD)
- Expanded data integrity requirements with full explanation
- Added complete MVP framework with success criteria
- Added P0/P1/P2 prioritization to all development phases
- Emphasized "baseline example, not ceiling" throughout

**Best for:** Detailed planning, feature specification, ongoing reference

---

## What These Updates Accomplish

✅ **Sets realistic expectations:** Developers understand $260k is opportunity analysis, not guaranteed delivery

✅ **Prevents over-specification:** Biosensor details TBD, so developers build flexible ingestion

✅ **Prioritizes correctly:** Data integrity is P0, not an afterthought

✅ **Focuses effort:** MVP first, validate, then expand (not build everything at once)

✅ **Aligns with business role:** Jeff defines business process and customer needs, not technical architecture

---

## Next Steps

1. **Share Executive Brief first** - Get developers oriented (15-min read)
2. **Discuss MVP scope** - Confirm Anomaly Detection as starting point
3. **Reference Detailed Document** - For deeper dive during planning
4. **Iterate based on feedback** - These are living documents

---

**Key Message to Developers:**

> "We're building the core information tool for oil sands tailings remediation. Start with MVP (anomaly detection + immutable data), validate with real users, then expand based on what operators actually need. Data integrity is non-negotiable from day 1. Biosensor formats are still being finalized, so build for flexibility. The $260k ROI shows what's possible - actual value will likely be higher as we discover site-specific optimizations."

---

**Documents Version:** 1.1 (Updated January 2026)
**Contact:** Jeff Violo (jeff.violo@luminousbiosolutions.com)
